Hexarelin 2mg × 10 vials

A synthetic growth hormone secretagogue studied for GH-release research, ghrelin receptor pathways, IGF-1 signaling, muscle-tissue models, recovery-related mechanisms, cardiac-function research, and broader endocrine regulation protocols.

Product Overview

Compound: Hexarelin
Strength: 2 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 2 mg
BAC water: 2 mL
Amount per unit: 10 mcg per unit

Research Dose

Protocol dependent.

Notes

Hexarelin is described as a synthetic growth hormone secretagogue peptide and ghrelin receptor agonist. It has been studied for its ability to stimulate growth hormone release through growth hormone secretagogue receptor pathways.

Research literature has examined Hexarelin in relation to GH pulsatility, IGF-1 signaling, endocrine regulation, muscle-tissue research, recovery-related pathways, appetite-related mechanisms, and body-composition models.

Hexarelin has also been studied in cardiovascular research contexts, including cardiac function, myocardial protection models, and heart-related cellular signaling.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.